Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Freiman Paul E. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/15/2023 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Exercised 858 restricted stock units @ $0
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/29/2020 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $0.89, valued at $17.8k
10/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2018 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $2.2, valued at $44k
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/20/2015 4 Freiman Paul E. (See Remarks) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 200,000 options to buy @ $0.8, valued at $160k
11/17/2015 4 Freiman Paul E. (See Remarks) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 1,667 preferred shares @ $0
Bought 166,667 options to buy @ $0.8, valued at $133.3k
Bought 166,667 options to buy @ $1.25, valued at $208.3k
Bought 166,667 options to buy @ $1, valued at $166.7k
Bought 166,667 options to buy @ $1.5, valued at $250k
01/06/2015 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 121,144 options to buy @ $0.64, valued at $77.5k
09/16/2014 4 Freiman Paul E. (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 50,000 options to buy @ $0.6, valued at $30k
01/09/2014 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $1.29, valued at $19.4k
01/15/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2012 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 30,000 shares @ $0.2, valued at $6k
Exercised (in-or-at-the-money) 30,000 options to buy @ $0.2, valued at $6k
01/05/2012 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 67,510 options to buy @ $1.33, valued at $89.8k
09/13/2011 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Bought 3,000 shares @ $0.84, valued at $2.5k
01/05/2011 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $1.67, valued at $25.1k
08/18/2010 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Sold 15,000 shares @ $1.83, valued at $27.5k
08/18/2010 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
Txns: Granted 1,428 shares @ $0
10/07/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
09/16/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
08/28/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
08/14/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
06/15/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
06/08/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
05/15/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
05/08/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities
04/01/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
03/30/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
03/23/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities
03/12/2009 4 Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy